Question 19
What are the regional differences in activity profiles between individual fluoroquinolones?
Further detailed comparison between individual fluoroquinolones confirmed the greater overall activity of levofloxacin, compared with moxifloxacin and ciprofloxacin throughout the entire 7 countries evaluated (Figure 2). As noted, the total susceptibility rates for levofloxacin ranged from 79% in Taiwan to 100% in Malaysia, Korea and the Philippines. In comparison, the overall susceptibility to moxifloxacin ranged from 14% in Indonesia, 19% in Taiwan, 53% in Hong Kong, 66% in Thailand, to a high of 68% in the Philippines, Malaysia and Korea. Ciprofloxacin susceptibility was also lower than that of levofloxacin, with 79% of Hong Kong isolates susceptible to ciprofloxacin, 93% in Thailand and Indonesia, 73% in Taiwan, and 78% in the Philippines, Malaysia, and Korea (Table 4).
Figure 2. Total ABECOPD pathogen susceptibility rate for three fluoroquinolones according to country of origin
Abbreviation: ABECOPD = acute bacterial exacerbations of chronic obstructive pulmonary disease.
Adapted from reference (16).
Table 4. Total ABECOPD pathogen susceptibility rate for three fluoroquinolones according to country of origin
Agent | Country |
||||||
Hong Kong | Taiwan | Indonesia | Korea | Philippines | Thailand | Malaysia | |
Levofloxacin | 93 | 79 | 95 | 100 | 100 | 97 | 100 |
Ciprofloxacin | 79 | 73 | 93 | 78 | 78 | 93 | 78 |
Moxifloxacin | 53 | 19 | 14 | 68 | 68 | 66 | 68 |
Abbreviation: ABECOPD = acute bacterial exacerbations of chronic obstructive pulmonary disease. Adapted from reference (16). |